Stephan Harbarth earned in 1993 his medical degree from Ludwig-Maximilians-University in Munich, Germany, and completed his residency in internal medicine and tropical medicine at Munich University Hospitals. After serving as a clinical fellow in the Infectious Diseases Division in the Department of Internal Medicine at Geneva University Hospitals, Dr Harbarth completed his master’s degree in epidemiology at Harvard School of Public Health. He is board certified in infectious diseases, was appointed full professor at the University of Geneva in 2018 and is the Director of the Infection Control Division and WHO Collaborating Center at Geneva Univ Hospitals since 2022. Dr Harbarth’s work has garnered several awards, incl. the prestigious Robert Koch Award (2022).
His research group has a strong academic track record. It is currently conducting several clinical and epidemiological studies to evaluate key questions related to the control of the acquisition, transmission and infection by multidrug-resistant microorganisms and related clinical and health-economic burden. He participates as WP leader in several ongoing large-scale EU-funded studies (REVERSE, PRIMAVERA, ECRAID, COMBACTE).